NCT06925737 · Interventional trial
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Overall registry status Recruiting
Phase 3
Conditions Prostate Cancer, Prostatic Neoplasms
Delaware Valley sites
- Abramson Cancer Center - Penn Medicine ( Site 0079) · Philadelphia, PA · Philadelphia County · Recruiting
- Perelman Center for Advanced Medicine ( Site 0067) · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory